These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
256 related articles for article (PubMed ID: 17259469)
21. Predictors of glycemic control and diabetes-related costs among type 2 diabetes patients initiating therapy with liraglutide in the United States. Durden E; Lenhart G; Lopez-Gonzalez L; Hammer M; Langer J J Med Econ; 2016; 19(4):403-13. PubMed ID: 26653068 [TBL] [Abstract][Full Text] [Related]
22. Factors associated with poor glycemic control among patients with type 2 diabetes. Khattab M; Khader YS; Al-Khawaldeh A; Ajlouni K J Diabetes Complications; 2010; 24(2):84-9. PubMed ID: 19282203 [TBL] [Abstract][Full Text] [Related]
23. Medication adherence and associated hemoglobin A1c in type 2 diabetes. Krapek K; King K; Warren SS; George KG; Caputo DA; Mihelich K; Holst EM; Nichol MB; Shi SG; Livengood KB; Walden S; Lubowski TJ Ann Pharmacother; 2004 Sep; 38(9):1357-62. PubMed ID: 15238621 [TBL] [Abstract][Full Text] [Related]
24. Glycated Hemoglobin Level Goal Achievement in Adults With Type 2 Diabetes in Canada: Still Room for Improvement. Leiter LA; Cheng AYY; Ekoé JM; Goldenberg RM; Harris SB; Hramiak IM; Khunti K; Lin PJ; Richard JF; Senior PA; Yale JF; Goldin L; Tan MK; Langer A Can J Diabetes; 2019 Aug; 43(6):384-391. PubMed ID: 30554985 [TBL] [Abstract][Full Text] [Related]
25. Loss of glycemic control in patients with type 2 diabetes mellitus who were receiving initial metformin, sulfonylurea, or thiazolidinedione monotherapy. Riedel AA; Heien H; Wogen J; Plauschinat CA Pharmacotherapy; 2007 Aug; 27(8):1102-10. PubMed ID: 17655510 [TBL] [Abstract][Full Text] [Related]
26. Predictive Validity of Self-Reported Measures of Adherence to Noninsulin Antidiabetes Medication against Control of Glycated Hemoglobin Levels. Zongo A; Guénette L; Moisan J; Grégoire JP Can J Diabetes; 2016 Feb; 40(1):58-65. PubMed ID: 26507401 [TBL] [Abstract][Full Text] [Related]
27. A randomized controlled trial of cognitive behavioral therapy for adherence and depression (CBT-AD) in patients with uncontrolled type 2 diabetes. Safren SA; Gonzalez JS; Wexler DJ; Psaros C; Delahanty LM; Blashill AJ; Margolina AI; Cagliero E Diabetes Care; 2014; 37(3):625-33. PubMed ID: 24170758 [TBL] [Abstract][Full Text] [Related]
28. Factors Associated with Poor Hemoglobin A1c Control in Patients with Type 2 Diabetes. Alqudah S; Jarab AS; Alefishat EA; Mayyas F; Khdour M; Pinto S Curr Diabetes Rev; 2019; 15(2):164-170. PubMed ID: 29745337 [TBL] [Abstract][Full Text] [Related]
29. A brief adherence intervention that improved glycemic control: mediation by patterns of adherence. de Vries McClintock HF; Morales KH; Small DS; Bogner HR J Behav Med; 2015 Feb; 38(1):39-47. PubMed ID: 24913600 [TBL] [Abstract][Full Text] [Related]
30. Clinical predictors of disease progression and medication initiation in untreated patients with type 2 diabetes and A1C less than 7%. Pani LN; Nathan DM; Grant RW Diabetes Care; 2008 Mar; 31(3):386-90. PubMed ID: 18083790 [TBL] [Abstract][Full Text] [Related]
31. Assessing the effectiveness of pharmacist-directed medication therapy management in improving diabetes outcomes in patients with poorly controlled diabetes. Skinner JS; Poe B; Hopper R; Boyer A; Wilkins CH Diabetes Educ; 2015 Aug; 41(4):459-65. PubMed ID: 26009557 [TBL] [Abstract][Full Text] [Related]
32. Medication Management Program: Adherence, Disease-related Knowledge, Health-related Quality of Life, and Glycemic Control for Type 2 Diabetes Mellitus. Nazir SUR; Hassali MA; Saleem F; Haque N Altern Ther Health Med; 2020 Jul; 26(S2):4-10. PubMed ID: 31634877 [TBL] [Abstract][Full Text] [Related]
33. Comparison of medication adherence and associated health care costs after introduction of pioglitazone treatment in African Americans versus all other races in patients with type 2 diabetes mellitus: a retrospective data analysis. Shenolikar RA; Balkrishnan R; Camacho FT; Whitmire JT; Anderson RT Clin Ther; 2006 Aug; 28(8):1199-1207. PubMed ID: 16982297 [TBL] [Abstract][Full Text] [Related]
34. National Rates of Initiation and Intensification of Antidiabetic Therapy Among Patients With Commercial Insurance. Gilstrap LG; Mehrotra A; Bai B; Rose S; Blair RA; Chernew ME Diabetes Care; 2018 Aug; 41(8):1776-1782. PubMed ID: 29794151 [TBL] [Abstract][Full Text] [Related]
35. Glycemic response to newly initiated diabetes therapies. Karter AJ; Moffet HH; Liu J; Parker MM; Ahmed AT; Go AS; Selby JV Am J Manag Care; 2007 Nov; 13(11):598-606. PubMed ID: 17988185 [TBL] [Abstract][Full Text] [Related]
36. The association between health beliefs and medication adherence among patients with type 2 diabetes. Alatawi YM; Kavookjian J; Ekong G; Alrayees MM Res Social Adm Pharm; 2016; 12(6):914-925. PubMed ID: 26706405 [TBL] [Abstract][Full Text] [Related]
37. Diabetes knowledge, medication adherence and glycemic control among patients with type 2 diabetes. Al-Qazaz HKh; Sulaiman SA; Hassali MA; Shafie AA; Sundram S; Al-Nuri R; Saleem F Int J Clin Pharm; 2011 Dec; 33(6):1028-35. PubMed ID: 22083724 [TBL] [Abstract][Full Text] [Related]
38. Glycemic response and attainment of A1C goals following newly initiated insulin therapy for type 2 diabetes. Nichols GA; Kimes TM; Harp JB; Kou TD; Brodovicz KG Diabetes Care; 2012 Mar; 35(3):495-7. PubMed ID: 22279033 [TBL] [Abstract][Full Text] [Related]
39. Canagliflozin treatment of Hispanic and non-Hispanic patients with type 2 diabetes in a US managed care setting. Chow W; Buysman E; Rupnow MF; Aguilar R; Henk HJ Curr Med Res Opin; 2016; 32(1):13-22. PubMed ID: 26414434 [TBL] [Abstract][Full Text] [Related]
40. Factors associated with clinical inertia in type 2 diabetes mellitus patients treated with metformin monotherapy. Kartoun U; Iglay K; Shankar RR; Beam A; Radican L; Chatterjee A; Pai JK; Shaw S Curr Med Res Opin; 2019 Dec; 35(12):2063-2070. PubMed ID: 31337263 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]